No profile data available.
Calidi Biotherapeutics, Inc. (CLDI) is a healthcare company in the additional cancer treatment drugs industry, based in San Diego, United States, with about 29 full-time employees.
In Q3 2025 (the quarter ended September 30, 2025) revenue was $0. Its market capitalization was $3.79 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
, a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease.
$3.79 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include NuCana plc (NCNA), PharmaCyte Biotech, Inc. (PMCB), Processa Pharmaceuticals, Inc. (PCSA), Indaptus Therapeutics, Inc. (INDP).